Human papillomavirus vaccination programmes
- 23 August 2007
- Vol. 335 (7616) , 357-358
- https://doi.org/10.1136/bmj.39302.707998.ae
Abstract
Footnotes Competing interests: BL is a member of a data and safety monitoring board for a clinical trial of an HIV vaccine, sponsored jointly by the National Institutes of Health and by Merck. Provenance and peer review: Commissioned; not peer reviewed.Keywords
This publication has 10 references indexed in Scilit:
- Effective Strategies for HPV Vaccine Delivery: The Views of PediatriciansJournal of Adolescent Health, 2007
- Challenges of implementing human papillomavirus (HPV) vaccination policyBMJ, 2007
- Politics, Parents, and Prophylaxis — Mandating HPV Vaccination in the United StatesNew England Journal of Medicine, 2007
- Mandatory HPV VaccinationPublished by American Medical Association (AMA) ,2007
- Push to mandate HPV vaccine triggers backlash in USAThe Lancet, 2007
- Acceptance of Human Papillomavirus Vaccination among Californian Parents of Daughters: A Representative Statewide AnalysisJournal of Adolescent Health, 2006
- HPV vaccine and adolescents' sexual activityBMJ, 2006
- Abstinence and abstinence-only education: A review of U.S. policies and programsJournal of Adolescent Health, 2006
- Measuring patient-centered communication in Patient–Physician consultations: Theoretical and practical issuesPublished by Elsevier ,2005
- “I Wish Things Were Different”: Expressing Wishes in Response to Loss, Futility, and Unrealistic HopesAnnals of Internal Medicine, 2001